Ghost-Tree-Capital

AI_NATIVE detailed information: This accession holds the following tickers:[
  "AXSM",
  "ASND",
  "EWTX",
  "INSM",
  "ABSI",
  "TGTX",
  "APLS",
  "RGNX",
  "ARVN",
  "ANNX",
  "OLMA",
  "CATX",
  "SVRA",
  "TSHA",
  "NUVB",
  "SMMT",
  "LRMR",
  "REPL",
  "PHAT",
  "SNDX",
  "NGNE",
  "AMLX",
  "JANX",
  "SYRE",
  "TARS",
  null,
  "KRRO",
  "PRQR",
  "TNYA",
  "ATYR",
  "RZLT",
  "RYTM",
  "MLTX",
  "SLNO",
  "DYN",
  "SRPT",
  "ROIV",
  null,
  null,
  "CRVS",
  "NVO",
  "VKTX",
  "VRDN",
  "IMVT",
  "PCVX",
  null,
  "BPMC",
  "BBIO",
  "CAPR",
  "CGON",
  "CRBP",
  "CRNX"
]

Filing Details

13F-HR • 2024-09-30

SEC FilingSEC DataHachi Filing

Report Date: 2024-09-30
Filing Date: 2024-11-14
Total Holdings: 52
Total Value: 322268332
Accession Number: 0001420506-24-002434
Form Type: 13F-HR
CIK: ghost-tree-capital
Manager Name: Ghost-Tree-Capital

Data Enrichment

92% identified

48 identified4 unidentified

Holdings

SEC FilingSEC DataHachi Filing

Manager:

52 positions • $322.3M total value

SEC FilingSEC DataHachi Filing

Manager:

Search and click to pin securities to the top

Page 3 of 3

Sort by:

Absci Corp

ABSI|00091E109

Shares:550.0K

Value:$2.1M

% of Portfolio:0.7% ($2.1M/$322.3M)

Neurogene Inc.

NGNE|64135M105

Shares:50.0K

Value:$2.1M

% of Portfolio:0.7% ($2.1M/$322.3M)

CAPRICOR THERAPEUTICS, INC.

CAPR|14070B309

Shares:125.0K

Value:$1.9M

% of Portfolio:0.6% ($1.9M/$322.3M)

Apellis Pharmaceuticals, Inc.

APLS|03753U106

Shares:65.0K

Value:$1.9M

% of Portfolio:0.6% ($1.9M/$322.3M)

Summit Therapeutics Inc.

SMMT|86627T108

Shares:85.0K

Value:$1.9M

% of Portfolio:0.6% ($1.9M/$322.3M)

Spyre Therapeutics, Inc.

SYRE|00773J202

Shares:60.0K

Value:$1.8M

% of Portfolio:0.5% ($1.8M/$322.3M)

Viridian Therapeutics, Inc.\DE

VRDN|92790C104

Shares:75.0K

Value:$1.7M

% of Portfolio:0.5% ($1.7M/$322.3M)

ProQR Therapeutics N.V.

PRQR|N71542109

Shares:887.7K

Value:$1.6M

% of Portfolio:0.5% ($1.6M/$322.3M)

aTYR PHARMA INC

ATYR|002120202

Shares:800.0K

Value:$1.4M

% of Portfolio:0.4% ($1.4M/$322.3M)

Larimar Therapeutics, Inc.

LRMR|517125100

Shares:200.0K

Value:$1.3M

% of Portfolio:0.4% ($1.3M/$322.3M)

29286M105

Shares:160.9K

Value:$1.1M

% of Portfolio:0.3% ($1.1M/$322.3M)

Amylyx Pharmaceuticals, Inc.

AMLX|03237H101

Shares:325.0K

Value:$1.1M

% of Portfolio:0.3% ($1.1M/$322.3M)

Instrument	Shares		Other Manager	Value	% of Portfolio
Absci Corp(ABSIcusip00091E109)	550.0K	QoQ NEW(+550.0K) YoY-	All Managers (Combined)	$2.1M	0.7% ($2.1M/$322.3M)	QoQ NEW(+$2.1M) YoY-
Neurogene Inc.(NGNEcusip64135M105)	50.0K	QoQ -28.57% (-20.0K) YoY-	All Managers (Combined)	$2.1M	0.7% ($2.1M/$322.3M)	QoQ -17.63% (-$449.3K) YoY-
CAPRICOR THERAPEUTICS, INC.(CAPRcusip14070B309)	125.0K	QoQ NEW(+125.0K) YoY-	All Managers (Combined)	$1.9M	0.6% ($1.9M/$322.3M)	QoQ NEW(+$1.9M) YoY-
Apellis Pharmaceuticals, Inc.(APLScusip03753U106)	65.0K	QoQ -51.85% (-70.0K) YoY-	All Managers (Combined)	$1.9M	0.6% ($1.9M/$322.3M)	QoQ -63.80% (-$3.3M) YoY-
Summit Therapeutics Inc.(SMMTcusip86627T108)	85.0K	QoQ NEW(+85.0K) YoY-	All Managers (Combined)	$1.9M	0.6% ($1.9M/$322.3M)	QoQ NEW(+$1.9M) YoY-
Spyre Therapeutics, Inc.(SYREcusip00773J202)	60.0K	QoQ -76.02% (-190.2K) YoY-	All Managers (Combined)	$1.8M	0.5% ($1.8M/$322.3M)	QoQ -70.00% (-$4.1M) YoY-
Viridian Therapeutics, Inc.\DE(VRDNcusip92790C104)	75.0K	QoQ -87.23% (-512.7K) YoY-	All Managers (Combined)	$1.7M	0.5% ($1.7M/$322.3M)	QoQ -77.68% (-$5.9M) YoY-
ProQR Therapeutics N.V.(PRQRcusipN71542109)	887.7K	QoQ -1.36% (-12.3K) YoY-	All Managers (Combined)	$1.6M	0.5% ($1.6M/$322.3M)	QoQ +8.14% (-$121.6K) YoY-
aTYR PHARMA INC(ATYRcusip002120202)	800.0K	QoQ 0.00% (+0) YoY-	All Managers (Combined)	$1.4M	0.4% ($1.4M/$322.3M)	QoQ +12.82% (+$160.0K) YoY-
Larimar Therapeutics, Inc.(LRMRcusip517125100)	200.0K	QoQ NEW(+200.0K) YoY-	All Managers (Combined)	$1.3M	0.4% ($1.3M/$322.3M)	QoQ NEW(+$1.3M) YoY-
(cusip29286M105)✕	160.9K	QoQ -61.72% (-259.4K) YoY-	All Managers (Combined)	$1.1M	0.3% ($1.1M/$322.3M)	QoQ -73.20% (-$2.9M) YoY-
Amylyx Pharmaceuticals, Inc.(AMLXcusip03237H101)	325.0K	QoQ NEW(+325.0K) YoY-	All Managers (Combined)	$1.1M	0.3% ($1.1M/$322.3M)	QoQ NEW(+$1.1M) YoY-